AGTX OTC
Agentix Corp.
1W: +0.0%
1M: +0.0%
3M: -5.2%
YTD: -46.7%
1Y: -55.6%
3Y: -80.9%
5Y: -98.4%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-05-27
Earliest Filing
2021-07-16
Latest Filing
target: 3
acquirer: 1
licensee: 1
Counterparties (Filed by AGTX)
5 relationshipsCompanies named in AGTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Applied Biopharma LLC | — | target | Target company in the merger agreement with Agentix Corp. | 2021-07-16 | View |
| Applied BioPharma LLC | — | target | Target of merger agreement to become wholly-owned subsidiary of Agentix Corp. | 2021-07-14 | View |
| AB Merger LLC | — | acquirer | Nevada LLC subsidiary of Agentix Corp. used as merger vehicle. | 2021-07-14 | View |
| Applied Biopharma LLC | — | target | Target of merger agreement (corrected name from Applied BioPharma LLC in filing text). | 2021-07-14 | View |
| National Health Research Institutes | — | licensee | Licensee of technology and patent rights for pyrazole compounds to treat Type 2 diabetes, obesity and fatty liver diseas | 2021-05-27 | View |
Recent 8-K Filings (4)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2022-06-14 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2021-07-16 | Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits | Acquisition | View |
| 2021-07-14 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2021-05-27 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR